New Jersey Assembly Bill A1875

New Jersey 2022-2023 Regular Session

• Introduced: 1/11/22
• Refer: 1/11/22

Caption

Establishes insulin assistance program.

Impact

The implementation of this program would allow pharmacies to register with the DHS and agree to reimbursement terms for dispensing insulin to qualifying individuals. Pharmacies that participate in this program will receive full reimbursement for the insulin products, thereby incentivizing them to provide necessary medications without upfront costs to the patients. This support could significantly impact individuals in financial distress, as it addresses the critical need for affordable insulin in the community.

Summary

Bill A1875 seeks to establish an insulin assistance program within the New Jersey Department of Human Services (DHS). The program aims to provide qualified individuals, particularly those without health insurance or means to purchase insulin, with access to insulin products and related supplies. These medications would be dispensed at no cost to eligible participants holding valid prescriptions. This initiative is a response to the financial burden faced by many diabetic patients in accessing necessary medication, emphasizing health equity.

Contention

There are notable points of contention regarding Bill A1875, particularly revolving around the availability and allocation of funds for the program's sustainability. Participation is contingent upon sufficient funding, which raises concerns over whether the program can provide continuous support without a clear financial source. As the bill necessitates applicants to document their financial inability to purchase insulin, questions arise about the bureaucratic process and the effectiveness of outreach to those most in need. Ensuring that eligible patients are aware of and can easily access the assistance program is critical for its success.